pionas.pom.go.idpionas.pom.go.id/sites/default/files/obat_baru/invega sustenna... · either 7 days...

9

Upload: lyanh

Post on 15-Mar-2019

219 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: pionas.pom.go.idpionas.pom.go.id/sites/default/files/obat_baru/Invega Sustenna... · either 7 days of immediate-release oral paliperidone once daily (titrated from 4 to B mg) or a

Page 2: pionas.pom.go.idpionas.pom.go.id/sites/default/files/obat_baru/Invega Sustenna... · either 7 days of immediate-release oral paliperidone once daily (titrated from 4 to B mg) or a

Page 3: pionas.pom.go.idpionas.pom.go.id/sites/default/files/obat_baru/Invega Sustenna... · either 7 days of immediate-release oral paliperidone once daily (titrated from 4 to B mg) or a

Page 4: pionas.pom.go.idpionas.pom.go.id/sites/default/files/obat_baru/Invega Sustenna... · either 7 days of immediate-release oral paliperidone once daily (titrated from 4 to B mg) or a

Page 5: pionas.pom.go.idpionas.pom.go.id/sites/default/files/obat_baru/Invega Sustenna... · either 7 days of immediate-release oral paliperidone once daily (titrated from 4 to B mg) or a

Page 6: pionas.pom.go.idpionas.pom.go.id/sites/default/files/obat_baru/Invega Sustenna... · either 7 days of immediate-release oral paliperidone once daily (titrated from 4 to B mg) or a

Page 7: pionas.pom.go.idpionas.pom.go.id/sites/default/files/obat_baru/Invega Sustenna... · either 7 days of immediate-release oral paliperidone once daily (titrated from 4 to B mg) or a

Page 8: pionas.pom.go.idpionas.pom.go.id/sites/default/files/obat_baru/Invega Sustenna... · either 7 days of immediate-release oral paliperidone once daily (titrated from 4 to B mg) or a

Page 9: pionas.pom.go.idpionas.pom.go.id/sites/default/files/obat_baru/Invega Sustenna... · either 7 days of immediate-release oral paliperidone once daily (titrated from 4 to B mg) or a

2008 - Paliperidone Extended-release Tablets for the Acute and Maintenance Treatment of Schizophrenia

Comparative Pharmacology of Risperidone and Paliperidone · Comparative Pharmacology of Risperidone and Paliperidone ... Universal Protein Resource and gene cards V3 ... Comparative

Invega Sustenna PI

Absorption, Metabolism, and Excretion of Paliperidone, a

INVEGA (paliperidone extended-release) Product Monograph for Canada

FORMULATION AND EVALUATION OF PALIPERIDONE …repository-tnmgrmu.ac.in/3646/1/261210901 Arun E M.pdf · “FORMULATION AND EVALUATION OF PALIPERIDONE SUSTAINED RELEASE TABLETS USING

Open Translational Science in Schizophrenia...2015/03/24 · 17 Paliperidone Trials 9 Disorders Schizophrenia Schizoaffective Disorder Bipolar Disorder Therapies Primary: Paliperidone

Assessment report - ema.europa.eu€¦ · CHMP Rapporteur Updated Assessment Report 17 April 2015 Opinion 23 April 2015 . 2. Scientific discussion 2.1. Introduction Invega tablets

Paliperidone NEW ZEALAND DATASHEET - Medsafe … · 2018-05-28 · CCDS171217 Page 1 of 26 INVEGA TABS (180327) ADS INVEGA® Paliperidone NEW ZEALAND DATASHEET 1. PRODUCT NAME INVEGA®

Australian public assessment for Paliperidone palmitate

"Experience of INVEGA with the use of financial engineering instruments in Lithuania 20 May 2011 JEREMIE NWP, Brussels Audrius Zabotka Deputy Director

Clinical Policy: Paliperidone Long-Acting Injections ......Invega Trinza is indicated for the treatment of schizophrenia in patients after they have been adequately treated with Invega

Australian Public Assessment Report fo Paliperidone · Invega (paliperidone) modified release tablets were first registered in September 2007 for the treatment of schizophrenia, including

AusPAR Attachment 1: Product Information for Paliperidone ... · Web viewCo-administration of a single dose of an oral paliperidone extended-release tablet 12 mg with divalproex sodium

Xeplion, INN-paliperidone palmitate - European Medicines Agency

INVEGA Extended-Release Tablets - Pusat Informasi Obat ...pionas.pom.go.id/sites/default/files/obat_baru/INVEGA 2012.pdf · INVEGA Extended-Release Tablets International Non-proprietary

Xeplion, INN-paliperidone palmitate

INVEGATM (paliperidone) Extended-Release Tablets Rx only ... · cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. INVEGATM (paliperidone)

Prescribing Information for INVEGA SUSTENNA

21999 Paliperidone Clinical Prea

NEW ZEALAND DATASHEET - Medsafe · NEW ZEALAND DATASHEET 1. PRODUCT NAME INVEGA SUSTENNA 25 mg Suspension for injection INVEGA SUSTENNA 50 mg Suspension for injection INVEGA SUSTENNA

Durham County Indigent Pharmacy Program (DCIPP) Formulary · 2020. 1. 29. · Abilify Maintena 300mg, 400mg Invega Sustenna 39mg, 78mg, 117mg, 156mg, ... A huge consumer group buying

Reference ID: 4119109(paliperidone palmitate) extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2006 . WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS

CADTH RAPID RESPONSE REPORT: SUMMARY WITH CRITICAL ... · population.8 Once-monthly injectable (Invega Sustenna®) and 3-month injectable (Invega Trinza®) paliperidone palmitate

INVEGATM (paliperidone) Extended-Release Tablets Rx only ...INVEGATM uses osmotic pressure to deliver paliperidone at a controlled rate. The delivery system, which resembles a capsule-shaped

NYP ACN-PAP Formulary: Spring 2010 A. · I-Caps Multivitamin Formula (eye vitamin & mineral supplement) Invega (paliperidone) Idamycin (idarubicin) Invega Sustenna (paliperidone palmitate)

Invega (paliperidone) extended release tablets€¦ · INVEGA ® (paliperidone) Extended-Release Tablets Initial U.S. Approval: 2006 . WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS

INVEGA SUSTENNA - Janssen - Pharmaceutical … for intramuscular injection in dose strengths of 25 mg, 50 mg, 75 mg, 100 mg and 150 mg ... trough ratio for a INVEGA SUSTENNA® dose

Transitioning patients to INVEGA TRINZA® DOSING · PDF filedosing and administration summary transitioning patients to invega trinza® warning: increased mortality in elderly patients

invega sustenna® product information

Invega Sustenna PI:Layout 1 - CSCC · monthly maintenance dose is 117 mg; ... QT interval and in patients with risk factors for prolonged QT interval ... To report SUSPECTED ADVERSE

Invega Extended Release Generic Name: paliperidone · PDF fileInvega Extended Release Generic Name: paliperidone Sponsor: Johnson & Johnson Pharmaceutical R. & D., LLC Approval Date:

Creation of better environment for SME growth - unece.org · Parks (6) SME’s Development Agency Lithuanian Development Agency Companies INVEGA & Business Support Agency. Public

Australian public assessment report for Paliperidone · Invega is indicated for the treatment of schizophrenia, including acute treatment and recurrence prevention. Invega is indicated

INVEGA SUSTENNA - janssen.com.au · Page 1 of 32 INVEGA SUSTENNA(150703) API INVEGA SUSTENNA® PRODUCT INFORMATION NAME OF THE MEDICINE Paliperidone palmitate . The chemical name